DAFNA Capital Management LLC - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 54 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2021$1,190,000
+16.7%
111,501
-1.6%
0.32%
+48.4%
Q2 2021$1,020,000
-15.1%
113,3020.0%0.21%
-25.3%
Q1 2021$1,201,000
-15.8%
113,302
+0.1%
0.28%
-32.8%
Q4 2020$1,426,000
+9.4%
113,202
-23.6%
0.42%0.0%
Q3 2020$1,303,000148,2600.42%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$17,640,0004.25%
BVF INC/IL 1,201,717$8,244,0000.92%
Orbimed Advisors 3,670,955$25,183,0000.39%
TIGER MANAGEMENT L.L.C. 137,728$945,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 475,450$3,262,0000.12%
Hikari Power Ltd 122,972$844,0000.09%
ALPINE WOODS CAPITAL INVESTORS, LLC 15,000$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,750$245,0000.00%
DRW Securities, LLC 10,000$69,0000.00%
VICTORY CAPITAL MANAGEMENT INC 134,542$923,0000.00%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders